I.R.C. Inc.

New bone and joint surgery research from K. Stoffel and colleagues discussed.
Medical Devices & Surgical Technology Week; 12/27/2009; 748 words; ...divided first (Weber B-r), followed sequentially...interosseous membrane (Weber C) and the deltoid ligament...rotation test for Weber C injuries and Weber C plus deltoid ligament injuries...Journal Bone Joint Surgery Inc., 20 Pickering St...

Dendreon Announces Proposed Public Offering of Common Stock.
Medical Letter on the CDC & FDA; 12/27/2009; 1006 words; ...any. J. P. Morgan Securities Inc. and Deutsche Bank Securities Inc. will act as joint book-running...commercialization of PROVENGE[R] (sipuleucel-T), for third...contacting: J.P. Morgan Securities Inc., c/o Broadridge Financial Solutions...

Study findings from M. Szewczyk et al provide new insights into heart transplants.(Report)
Heart Disease Weekly; 12/27/2009; 878 words; ...the transplant group (R = -.09; P =.25) or in the control cohort (R = .22; P = .36). In...with serum creatinine (R = .27; P = .001...Correlations With Cystatin C, Serum Creatinine, and...Proceedings is: Elsevier Science Inc., 360 Park Avenue South...

Studies from University Hospital further understanding of type 2 diabetes.
Heart Disease Weekly; 12/27/2009; 698 words; ...mRNA expression in ZDF rats (r = 0.99 and 0.96). Consistent...in diabetic patients," wrote C. Burgdorf and colleagues, University...For more information, contact C. Burgdorf, University Hospital...Communications is: Academic Press Inc. Elsevier Science, 525 B St...

Dendreon Announces Pricing of Common Stock Offering.
Medical Letter on the CDC & FDA; 12/27/2009; 1188 words; ...Deutsche Bank Securities Inc. acted as joint book-running...Citigroup Global Markets Inc., Morgan Stanley & Co...commercialization of PROVENGE[R] (sipuleucel-T), for...J.P. Morgan Securities Inc., c/o Broadridge Financial...